BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Cassava Sciences Initiates a Second Phase 3 Study of Simufilam for the Treatment of Patients with Alzheimer’s Disease

  Cassava Sciences, Inc., a biotechnology company, announced it has initiated a second Phase 3 study of simufilam, the Company’s investigational drug for patients with Alzheimer’s disease.

  November 18, 2021

   · 

  5 min read
• Business

  Zynex Ranked 7th in Revenue Growth Among Medical Device Companies

  Zynex, Inc. announced it has been ranked 7th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte’s 2021 Technology Fast 500.

  November 18, 2021

   · 

  3 min read
• Business

  LifeSprout, Inc. Appoints Michael Kranda as CEO and Director

  LifeSprout, Inc., a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, announced the appointment of Michael Kranda as CEO and member of the board of directors.

  November 18, 2021

   · 

  2 min read
• Business

  Cellevolve Launches with Acclaimed Investors and Pivotal Manufacturing Partnership, Focused on Accelerating the Commercialization of Novel Cell Therapies

  Cellevolve Bio, a development and commercialization company focused on cell therapies, announced its launch following the successful close of seed financing and an exclusive manufacturing partnership with National Resilience, Inc., a biopharmaceutical manufacturing company supply.

  November 18, 2021

   · 

  4 min read